Header Logo

Connection

Shabir Madhi to Vaccination

Back to Details
This is a "connection" page, showing publications Shabir Madhi has written about Vaccination.
Shabir Madhi
Connection Strength
12,106
Vaccination
  1. Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization. Expert Rev Vaccines. 2020 04; 19(4):383-393.
    View in: PubMed
    Score: 0,584
  2. Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women. PLoS One. 2018; 13(12):e0210124.
    View in: PubMed
    Score: 0,535
  3. Special focus on challenges and opportunities for the development and use of vaccines in Africa. Hum Vaccin Immunother. 2018; 14(10):2335-2339.
    View in: PubMed
    Score: 0,525
  4. Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014. Vaccine. 2018 11 12; 36(47):7231-7237.
    View in: PubMed
    Score: 0,493
  5. Prospects for preventing infant invasive GBS disease through maternal vaccination. Vaccine. 2017 08 16; 35(35 Pt A):4457-4460.
    View in: PubMed
    Score: 0,470
  6. Hospitalization for Culture-confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization. Pediatr Infect Dis J. 2017 01; 36(1):e14-e21.
    View in: PubMed
    Score: 0,466
  7. Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine (Baltimore). 2017 Jan; 96(2):e5881.
    View in: PubMed
    Score: 0,466
  8. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa. Clin Infect Dis. 2016 May 01; 62 Suppl 2:S188-95.
    View in: PubMed
    Score: 0,444
  9. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016 08; 16(8):923-34.
    View in: PubMed
    Score: 0,444
  10. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016; 12(2):314-25.
    View in: PubMed
    Score: 0,434
  11. Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis. J Pediatr (Rio J). 2015 Mar-Apr; 91(2):108-10.
    View in: PubMed
    Score: 0,403
  12. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine. 2012 Apr 27; 30 Suppl 1:A44-51.
    View in: PubMed
    Score: 0,337
  13. Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011 Feb; 101(2):126-31.
    View in: PubMed
    Score: 0,309
  14. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis. 2009 Apr 15; 199(8):1168-76.
    View in: PubMed
    Score: 0,273
  15. Vaccine stock-outs: A preventable health facility obstacle contributing to missed vaccinations in South African children. Vaccine. 2025 Jan 25; 45:126583.
    View in: PubMed
    Score: 0,202
  16. Vaccine value profile for Klebsiella pneumoniae. Vaccine. 2024 Jul 25; 42(19S1):S125-S141.
    View in: PubMed
    Score: 0,192
  17. Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV. AIDS. 2023 12 01; 37(15):2305-2310.
    View in: PubMed
    Score: 0,186
  18. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
    View in: PubMed
    Score: 0,180
  19. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis. 2023 03; 23(3):295-306.
    View in: PubMed
    Score: 0,174
  20. Vaccination of the HIV-1 infected child. SADJ. 2001 Dec; 56(12):610-3.
    View in: PubMed
    Score: 0,164
  21. The Etiology of Pneumonia in HIV-uninfected South African Children: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 09 01; 40(9S):S59-S68.
    View in: PubMed
    Score: 0,161
  22. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
    View in: PubMed
    Score: 0,160
  23. Epidemiology of severe COVID-19 from South Africa. Lancet HIV. 2021 09; 8(9):e524-e526.
    View in: PubMed
    Score: 0,160
  24. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 07 30; 383(5):426-439.
    View in: PubMed
    Score: 0,149
  25. Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 2020 02 28; 38(10):2350-2360.
    View in: PubMed
    Score: 0,144
  26. The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019 05 27; 37(24):3190-3198.
    View in: PubMed
    Score: 0,137
  27. Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants. PLoS One. 2019; 14(4):e0215079.
    View in: PubMed
    Score: 0,136
  28. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
    View in: PubMed
    Score: 0,133
  29. Influenza Vaccination during Pregnancy and Protection against Pertussis. N Engl J Med. 2018 03 29; 378(13):1257-1258.
    View in: PubMed
    Score: 0,127
  30. Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy. Clin Infect Dis. 2017 Nov 13; 65(11):1897-1904.
    View in: PubMed
    Score: 0,124
  31. Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis. Hum Vaccin Immunother. 2018 03 04; 14(3):758-766.
    View in: PubMed
    Score: 0,123
  32. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial. Clin Infect Dis. 2017 10 01; 65(7):1066-1071.
    View in: PubMed
    Score: 0,123
  33. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials. Clin Infect Dis. 2017 Jun 15; 64(12):1773-1779.
    View in: PubMed
    Score: 0,120
  34. Etiology of Acute Otitis Media in Children Less Than 5 Years of Age: A Pooled Analysis of 10 Similarly Designed Observational Studies. Pediatr Infect Dis J. 2017 03; 36(3):274-281.
    View in: PubMed
    Score: 0,118
  35. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,117
  36. Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS One. 2016; 11(12):e0169101.
    View in: PubMed
    Score: 0,116
  37. The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S165-S173.
    View in: PubMed
    Score: 0,116
  38. Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S174-S180.
    View in: PubMed
    Score: 0,116
  39. The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis. Am J Perinatol. 2016 09; 33(11):1104-14.
    View in: PubMed
    Score: 0,114
  40. Knowledge, attitudes, and practices about influenza illness and vaccination: a cross-sectional survey in two South African communities. Influenza Other Respir Viruses. 2016 09; 10(5):421-8.
    View in: PubMed
    Score: 0,111
  41. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference. Pan Afr Med J. 2016; 23:53.
    View in: PubMed
    Score: 0,110
  42. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa. J Infect Dis. 2015 Oct 01; 212(7):1082-92.
    View in: PubMed
    Score: 0,103
  43. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014 Apr 07; 32(17):1954-63.
    View in: PubMed
    Score: 0,095
  44. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013 Aug 28; 31 Suppl 4:D52-7.
    View in: PubMed
    Score: 0,092
  45. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children. Vaccine. 2013 Sep 13; 31(40):4421-7.
    View in: PubMed
    Score: 0,091
  46. Review of a new fully liquid, hexavalent vaccine: Hexaxim. Expert Opin Biol Ther. 2013 Apr; 13(4):575-93.
    View in: PubMed
    Score: 0,089
  47. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012 Sep 13; 12:213.
    View in: PubMed
    Score: 0,086
  48. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
    View in: PubMed
    Score: 0,086
  49. Benefits to mother and child of influenza vaccination during pregnancy. Hum Vaccin Immunother. 2012 Jan; 8(1):130-7.
    View in: PubMed
    Score: 0,082
  50. The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J. 2011; 8:24.
    View in: PubMed
    Score: 0,078
  51. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S57-62.
    View in: PubMed
    Score: 0,071
  52. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006 Mar 20; 24(13):2432-9.
    View in: PubMed
    Score: 0,054
  53. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J. 2005 May; 24(5):410-6.
    View in: PubMed
    Score: 0,052
  54. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response. Nat Med. 2024 May; 30(5):1384-1394.
    View in: PubMed
    Score: 0,048
  55. Impact of nutritional status on vaccine-induced immunity in children living in South Africa: Investigating the B-cell repertoire and metabolic hormones. Vaccine. 2024 May 22; 42(14):3337-3345.
    View in: PubMed
    Score: 0,048
  56. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination. Front Immunol. 2023; 14:1231276.
    View in: PubMed
    Score: 0,046
  57. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023 07; 24(7):1161-1172.
    View in: PubMed
    Score: 0,046
  58. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20; 388(16):1451-1464.
    View in: PubMed
    Score: 0,045
  59. Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021. Vaccine. 2022 07 30; 40(32):4283-4291.
    View in: PubMed
    Score: 0,043
  60. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV. Front Immunol. 2022; 13:873191.
    View in: PubMed
    Score: 0,042
  61. Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case. Vaccine. 2022 03 15; 40(12):1681-1690.
    View in: PubMed
    Score: 0,041
  62. Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders. Front Immunol. 2021; 12:808064.
    View in: PubMed
    Score: 0,041
  63. South Africa should be using all the COVID-19 vaccines available to it - urgently. S Afr Med J. 2021 03 25; 111(5):390-392.
    View in: PubMed
    Score: 0,039
  64. Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement. Front Immunol. 2020; 11:1282.
    View in: PubMed
    Score: 0,037
  65. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa. Clin Infect Dis. 2020 04 10; 70(8):1606-1612.
    View in: PubMed
    Score: 0,037
  66. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study. Clin Microbiol Infect. 2020 Apr; 26(4):515.e1-515.e4.
    View in: PubMed
    Score: 0,035
  67. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect. 2018 11; 77(5):368-378.
    View in: PubMed
    Score: 0,032
  68. Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali and South Africa. Pediatr Infect Dis J. 2018 05; 37(5):436-440.
    View in: PubMed
    Score: 0,032
  69. Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines. Vaccine. 2017 10 13; 35(43):5734-5737.
    View in: PubMed
    Score: 0,031
  70. Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017 06 05; 35(25):3303-3308.
    View in: PubMed
    Score: 0,030
  71. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017 06 05; 35(25):3295-3302.
    View in: PubMed
    Score: 0,030
  72. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016. Vaccine. 2019 11 28; 37(50):7307-7314.
    View in: PubMed
    Score: 0,029
  73. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
    View in: PubMed
    Score: 0,029
  74. Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study. Clin Infect Dis. 2016 Dec 01; 63(suppl 4):S187-S196.
    View in: PubMed
    Score: 0,029
  75. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
    View in: PubMed
    Score: 0,029
  76. The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa. Vaccine. 2016 07 19; 34(33):3713-4.
    View in: PubMed
    Score: 0,028
  77. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,027
  78. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016 May; 16(5):546-555.
    View in: PubMed
    Score: 0,027
  79. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,027
  80. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015 Nov; 3(11):888-900.
    View in: PubMed
    Score: 0,027
  81. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,025
  82. Safety of licensed vaccines in HIV-infected persons: a systematic review protocol. Syst Rev. 2014 Sep 11; 3:101.
    View in: PubMed
    Score: 0,025
  83. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS One. 2012; 7(1):e27793.
    View in: PubMed
    Score: 0,021
  84. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine. 2012 Jan 11; 30(3):565-71.
    View in: PubMed
    Score: 0,020
  85. A DTaP-IPV//PRP~T vaccine (Pentaxim): a review of 16 years' clinical experience. Expert Rev Vaccines. 2011 Jul; 10(7):981-1005.
    View in: PubMed
    Score: 0,020
  86. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. Pediatr Infect Dis J. 2011 Feb; 30(2):125-30.
    View in: PubMed
    Score: 0,019
  87. Childhood bacterial respiratory diseases: past, present, and future. Pediatr Infect Dis J. 2009 Oct; 28(10 Suppl):S127-32.
    View in: PubMed
    Score: 0,018
  88. Influenza guideline for South Africa--update 2008. S Afr Med J. 2008 Mar; 98(3 Pt 2):224-30.
    View in: PubMed
    Score: 0,016
  89. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis. 2006 Feb 15; 193(4):573-81.
    View in: PubMed
    Score: 0,014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.